Annual Total Debt
$238.63 M
-$5.39 M-2.21%
31 December 2023
Summary:
CRISPR Therapeutics AG annual total debt is currently $238.63 million, with the most recent change of -$5.39 million (-2.21%) on 31 December 2023. During the last 3 years, it has risen by +$177.20 million (+288.47%). CRSP annual total debt is now -2.21% below its all-time high of $244.02 million, reached on 31 December 2022.CRSP Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Debt
$227.54 M
-$3.76 M-1.62%
30 September 2024
Summary:
CRISPR Therapeutics AG quarterly total debt is currently $227.54 million, with the most recent change of -$3.76 million (-1.62%) on 30 September 2024. Over the past year, it has dropped by -$14.04 million (-5.81%). CRSP quarterly total debt is now -7.19% below its all-time high of $245.18 million, reached on 30 June 2023.CRSP Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRSP Total Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -2.2% | -5.8% |
| 3 y3 years | +288.5% | +10.8% |
| 5 y5 years | +100.0% | +446.6% |
CRSP Total Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -2.2% | +288.5% | -7.2% | +10.8% |
| 5 y | 5 years | -2.2% | -7.2% | +446.6% | |
| alltime | all time | -2.2% | -7.2% |
CRISPR Therapeutics AG Total Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $227.54 M(-1.6%) |
| June 2024 | - | $231.30 M(-1.5%) |
| Mar 2024 | - | $234.93 M(-1.6%) |
| Dec 2023 | $238.63 M(-2.2%) | $238.63 M(-1.2%) |
| Sept 2023 | - | $241.59 M(-1.5%) |
| June 2023 | - | $245.18 M(+2.0%) |
| Mar 2023 | - | $240.27 M(-1.5%) |
| Dec 2022 | $244.02 M(+8.4%) | $244.02 M(+0.8%) |
| Sept 2022 | - | $242.16 M(-0.1%) |
| June 2022 | - | $242.43 M(+1.4%) |
| Mar 2022 | - | $238.98 M(+6.2%) |
| Dec 2021 | $225.03 M(+266.3%) | $225.03 M(+9.6%) |
| Sept 2021 | - | $205.38 M(+7.4%) |
| June 2021 | - | $191.20 M(+211.0%) |
| Mar 2021 | - | $61.47 M(+0.1%) |
| Dec 2020 | $61.43 M(+16.9%) | $61.43 M(+24.8%) |
| Sept 2020 | - | $49.21 M(-2.0%) |
| June 2020 | - | $50.22 M(-2.3%) |
| Mar 2020 | - | $51.40 M(-2.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2019 | $52.54 M(>+9900.0%) | $52.54 M(+26.2%) |
| Sept 2019 | - | $41.63 M(-1.1%) |
| June 2019 | - | $42.08 M(+14.9%) |
| Mar 2019 | - | $36.63 M(>+9900.0%) |
| Dec 2018 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2018 | - | $0.00(0.0%) |
| June 2018 | - | $0.00(0.0%) |
| Mar 2018 | - | $0.00(0.0%) |
| Dec 2017 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2017 | - | $0.00(0.0%) |
| June 2017 | - | $0.00(0.0%) |
| Mar 2017 | - | $0.00(0.0%) |
| Dec 2016 | $0.00(-100.0%) | $0.00(0.0%) |
| Sept 2016 | - | $0.00(0.0%) |
| June 2016 | - | $0.00(0.0%) |
| Mar 2016 | - | $0.00(-100.0%) |
| Dec 2015 | $38.34 M(>+9900.0%) | $38.34 M(>+9900.0%) |
| Sept 2015 | - | $0.00 |
| Dec 2014 | $0.00 | - |
FAQ
- What is CRISPR Therapeutics AG annual total debt?
- What is the all time high annual total debt for CRISPR Therapeutics AG?
- What is CRISPR Therapeutics AG annual total debt year-on-year change?
- What is CRISPR Therapeutics AG quarterly total debt?
- What is the all time high quarterly total debt for CRISPR Therapeutics AG?
- What is CRISPR Therapeutics AG quarterly total debt year-on-year change?
What is CRISPR Therapeutics AG annual total debt?
The current annual total debt of CRSP is $238.63 M
What is the all time high annual total debt for CRISPR Therapeutics AG?
CRISPR Therapeutics AG all-time high annual total debt is $244.02 M
What is CRISPR Therapeutics AG annual total debt year-on-year change?
Over the past year, CRSP annual total debt has changed by -$5.39 M (-2.21%)
What is CRISPR Therapeutics AG quarterly total debt?
The current quarterly total debt of CRSP is $227.54 M
What is the all time high quarterly total debt for CRISPR Therapeutics AG?
CRISPR Therapeutics AG all-time high quarterly total debt is $245.18 M
What is CRISPR Therapeutics AG quarterly total debt year-on-year change?
Over the past year, CRSP quarterly total debt has changed by -$14.04 M (-5.81%)